Novartis AG ADR sell The Goldman Sachs Group, Inc.
Start price
12.09.25
/
50%
€106.50
Target price
12.09.26
€100.61
Performance (%)
20.19%
Price
16.04.26
€128.00
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 20.19%. This prediction currently runs until 12.09.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novartis AG ADR | -3.759% | -3.759% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novartis AG ADR diskutieren
Novartis (NYSE:NVS) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $118.00 price target on the stock, down previously from $119.00.
Ratings data for NVS provided by MarketBeat